The promoter of BioBloodChip recently formalized the establishment of their company alongside the rector of Miguel Hernández University (UMH) in Elche. This biomedical firm focuses on the design and development of an in vitro diagnostic screening device for the early detection of metastasis.

The tool developed by BioBloodChip allows for the detection of minimal residual disease even before it is visible with other tests, providing an early alert and a rapid response in a non-invasive manner. This project was recognized at the 14th UMH Marathon and received an award from Laboratorios Quinton, the UMH Social Council, and AEPA.

Furthermore, the company was honored in the 'University Startup 2025' category of the Santander X Spain Awards. With its incorporation, BioBloodChip becomes part of the business network of the UMH Science Park, which currently comprises nearly a hundred innovative companies.